Information for you
On this page, you will find information on the Agency’s activities that are most relevant to patients and carers, including news, and events.
You can contribute to the Agency’s work by responding to public consultations.
Learn more about how Patients and carers are actively involved in the work of the Agency.
Information session on biosimilars
The Agency held an information session on biosimilars aiming to provide an overview of the science behind biosimilars and how they are evaluated by regulators. The session also explored public acceptability of biosimilars and the role of communication in promoting better understanding of biosimilar medicines.
European public assessment reports (EPARs)
Use this tool to search all EPARs for human medicines published by the European Medicines Agency (EMA). The information presented includes public-friendly summaries in question-and-answer format and the package leaflets. See our page on background and context for more information on EPARs.
Newsletter - Human medicines highlights
This newsletter is addressed primarily to organisations representing patients, consumers and healthcare professionals. It provides a summary of key information relating to medicines for human use by disease area published during the previous month by EMA.
Beware of falsified medicines!
Falsified medicines are fake medicines that may enter the supply chain illegally. Be careful about the way you buy medicines. For internet sales, the European Commission has introduced a common logo that appears on the websites of authorised online retailers to reduce the risk of buying falsified medicines online.
News for patients and carers
Summaries to help people make informed choices when taking herbal medicines ... Read more
Expressions of interest to represent civil society at PRAC and CAT to be submitted to European Commission by 30 September 2015 ... Read more
Ten new medicines recommended for authorisation in the EU, and first malaria vaccine receives positive scientific opinion for use outside the EU ... Read more
Mosquirix to be used for vaccination of young children, together with established antimalarial interventions ... Read more
Medicine to offer therapy for patients unable to control high cholesterol with currently available treatment ... Read more
- See all News for patients and carers
Events of interest
The aim of the meeting is to develop ways to work together that optimise the design and conduct of neonatal medicines research in Europe. During this meeting we will share perspectives about the current state of neonatal medicines research in Europe, review “hot topics” and prioritise them, and develop an action plan for 2015. Registration by invitation only. ... Read more
European Medicines Agency Human Scientific Committees' Working Party with Patients’ and Consumers’ Organisations (PCWP) meeting
This is a meeting with representatives of the Patients' and Consumers' Organisations Working Party (PCWP). Patients and consumers will share their experiences on initiatives they are involved in and will discuss PCWP involvement in preparation of guidelines on the summary of clinical trial results for laypersons. Other topics such as the involvement of patient representatives in EMA committees, and FDA engagement with patients and the activities organised to mark the PCWP’s 10th anniversary will also be discussed. Registration by invitation only. ... Read more
28/05/2015 - 29/05/2015
Annual workshop of the European network of paediatric research at the European Medicines Agency (Enpr-EMA)
Day one of the workshop, 28 May, is an open meeting to all stakeholders: patient/parent organisations, network representatives, pharmaceutical industry staff responsible for paediatric studies and regulators. Day two, 29 May, is dedicated to members of Enpr-EMA and its Coordinating Group. Registration is open until 15 May 2015 using the registration form. ... Read more
European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting: workshop on risk minimisation measures
This is a workshop on risk minimisation measures with representatives from patients’, consumers’ and healthcare professionals’ organisations. An overview of the regulatory environment supporting the development of risk minimisation measures will be provided to participants; In addition, current practices/experience in the implementation and evaluation of the effectiveness of additional risk minimisation measures will be shared, using concrete examples. Participants will also discuss challenges and opportunities posed by the implementation and evaluation of risk minimisation measures in real life clinical practice. Registration by invitation only. ... Read more
European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting
This is a joint meeting with representatives from patients’, consumers’ and healthcare professionals’ organisations. Participants will discuss the PCWP/HCPWP work programmes for 2016. They will be updated on a number of initiatives and ongoing activities including the need for collaboration in pharmacovigilance to ensure effective health protection and promotion, the new pharmacovigilance systems and services. Participants will be presented with the results of the survey to National Competent Authorities and the results from VISUALIZE research study (PROTECT project). Other topics including the progress of the PCWP/HCPWP topic groups, feedback from the scientific committees, patients' and consumers' and healthcare professionals' organisations projects and initiatives will also be presented. Registration by invitation only. ... Read more
- See all Events of interest